SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (26506)11/16/1998 12:18:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
bluejeans, I had linked two versions of the Legg Mason report. Both were at biocognizance.com and only the first was at webf2179.ntx.net . However, I have now linked both reports to both sites. Sometimes you have to hit "reload" on your browser to see the latest version.



To: bluejeans who wrote (26506)11/16/1998 12:46:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Dow Jones headline is Approval:

Ligand Pharmaceuticals Inc.
Dow Jones Newswires -- November 16, 1998
FDA Panel Backs Ligand's AIDS Tumor Gel, Panretin

timestamp is 12:38


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News